წყაროები
ძირითადი სტატიები
Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Aug;74(2):1014-48.სრული ტექსტი აბსტრაქტი
European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-60.სრული ტექსტი აბსტრაქტი
გამოყენებული სტატიები
1. Rimola A, Garcia-Tsao G, Navasa M, et al; International Ascites Club. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000 Jan;32(1):142-53.სრული ტექსტი აბსტრაქტი
2. Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1984 Nov-Dec;4(6):1209-11. აბსტრაქტი
3. Terg R, Levi D, Lopez P, et al. Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites area: evidence of the same disease. Dig Dis Sci. 1992 Oct;37(10):1499-504. აბსტრაქტი
4. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001 Jan-Feb;33(1):41-8. აბსტრაქტი
5. Dhiman RK, Makharia JK, Jain S, et al. Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. Am J Gastroenterol. 2000 Jan;95(1):233-8. აბსტრაქტი
6. Blaise M, Pateron D, Trinchet JC, et al. Systemic antibiotic therapy prevents bacterial infections in cirrhotic patients presenting with gastrointestinal hemorrhage. Hepatology. 1994 Jul;20(1 Pt 1):34-8. აბსტრაქტი
7. Bleichner G, Boulanger R, Squara P, et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg. 1986 Sep;73(9):724-6. აბსტრაქტი
8. Evans LT, Kim WR, Poterucha JJ, et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003 Apr;37(4):897-901.სრული ტექსტი აბსტრაქტი
9. Jeffries MA, Stern MA, Gunaratnam NT, et al. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis. Am J Gastroenterol. 1999 Oct;94(10):2972-6. აბსტრაქტი
10. Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005 Feb;25(1):57-61. აბსტრაქტი
11. Campillo B, Richardet JP, Kheo T, et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002 Jul 1;35(1):1-10.სრული ტექსტი აბსტრაქტი
12. Oliveira JC, Carrera E, Petry RC, et al. High prevalence of multidrug resistant bacteria in cirrhotic patients with spontaneous bacterial peritonitis: is it time to change the standard antimicrobial approach? Can J Gastroenterol Hepatol. 2019;2019:6963910.სრული ტექსტი აბსტრაქტი
13. Al-Ghamdi H, Al-Harbi N, Mokhtar H, et al. Changes in the patterns and microbiology of spontaneous bacterial peritonitis: analysis of 200 cirrhotic patients. Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):261-6.სრული ტექსტი აბსტრაქტი
14. Parsi MA, Atreja A, Zein NN. Spontaneous bacterial peritonitis: recent data on incidence and treatment. Cleve Clin J Med. 2004 Jul;71(7):569-76. აბსტრაქტი
15. Alexopoulou A, Papadopoulos N, Eliopoulos DG, et al. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int. 2013 Aug;33(7):975-81. აბსტრაქტი
16. Piano S, Romano A, Rosi S, et al. Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1234-7. აბსტრაქტი
17. Boixeda D, De Luis DA, Aller R, et al. Spontaneous bacterial peritonitis: clinical and microbiological study of 233 episodes. J Clin Gastroenterol. 1996 Dec;23(4):275-9. აბსტრაქტი
18. Singh N, Wagener MM, Gayowski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect. 2003 Jun;9(6):531-7.სრული ტექსტი აბსტრაქტი
19. Kamani L, Mumtaz K, Ahmed US, et al. Outcomes in culture positive and culture negative ascitic fluid infections in patients with viral cirrhosis: cohort study. BMC Gastroenterol. 2008 Dec 18;8:59. აბსტრაქტი
20. Espinoza-Gómez F, Newton-Sánchez O, Melnikov V, et al. Spontaneous bacterial peritonitis caused by Listeria in a patient with cirrhosis: case report [in Spanish]. Rev Med Chil. 2006 Sep;134(9):1171-4.სრული ტექსტი აბსტრაქტი
21. Musher DM, Nichol AC, Rueda AM. Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis. J Clin Microbiol. 2006 Jun;44(6):2304-6.სრული ტექსტი აბსტრაქტი
22. Dimopoulou A, Dimopoulou D, Christianakis E, et al. Spontaneous bacterial peritonitis caused by nontypeable Haemophilus influenzae in a previously healthy child. Pediatr Infect Dis J. 2013 Jun;32(6):704. აბსტრაქტი
23. Brautbar A, Esayag Y, Breuer GS, et al. Spontaneous bacterial peritonitis caused by Haemophilus parainfluenzae. Isr Med Assoc J. 2007 Mar;9(3):175-6. აბსტრაქტი
24. Nathanson L. Spontaneous bacterial peritonitis due to Neisseria meningitides serogroup Z. Clin Pediatr (Phila). 1993 Aug;32(8):510. აბსტრაქტი
25. Lecliere S, Di Fiore F, Hervé S, et al. Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin [in French]. Presse Med. 2003 Mar 29;32(12):550-2. აბსტრაქტი
26. Adhikary R, Joshi S, Venugopa RV, et al. Spontaneous bacterial peritonitis caused by S. paratyphi A. J Assoc Physicians India. 2013 Dec;61(12):930-31. აბსტრაქტი
27. Kim HM, Chon CY, Ahn SH, et al. Fatal spontaneous bacterial peritonitis by Leclercia adecarboxylata in a patient with hepatocellular carcinoma. Int J Clin Pract. 2008 Aug;62(8):1296-8. აბსტრაქტი
28. Dalamaga M, Karmaniolas K, Pantelaki M, et al. Spontaneous peritonitis caused by Leminorella grimontii. Diagn Microbiol Infect Dis. 2006 Sep;56(1):83-5. აბსტრაქტი
29. Colakoglu S, Turunc T, Taskoparan M, et al. Three cases of serious infection caused by Aerococcus urinae: a patient with spontaneous bacterial peritonitis and two patients with bacteremia. Infection. 2008 Jun;36(3):288-90. აბსტრაქტი
30. Velayos Jiménez B, Fernández Salazar L, Aller Fuente R, et al. Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin [in Spanish]. Gastroenterol Hepatol. 2008 Mar;31(3):129. აბსტრაქტი
31. Flores-Franco RA, Lachica-Rodriguez GN, Banuelos-Moreno L, et al. Spontaneous peritonitis attributed to actinomyces species. Ann Hepatol. 2007 Oct-Dec;6(4):276-8. აბსტრაქტი
32. Gautam M, Chopra KB, Douglas DD, et al. Streptococcus salivarius bacteremia and spontaneous bacterial peritonitis in liver transplantation candidates. Liver Transpl. 2007 Nov;13(11):1582-8.სრული ტექსტი აბსტრაქტი
33. Wi YM, Sohn KM, Rhee JY, et al. Spontaneous bacterial peritonitis due to Ochrobactrum anthropi: a case report. J Korean Med Sci. 2007 Apr;22(2):377-9.სრული ტექსტი აბსტრაქტი
34. Farmer AD, Bruckner Holt CE, Le Roux G, et al. Spontaneous bacterial peritonitis due to Arcanobacterium haemolyticum. J Infect. 2007 May;54(5):516. აბსტრაქტი
35. Singh DK, Tyagi I, Saran RK, et al. Fatal spontaneous Cryptococcal peritonitis in a woman with decompensated liver cirrhosis. Acta Cytol. 2010 Sep-Oct;54(5 Suppl):1087-9. აბსტრაქტი
36. Bal CK, Bhatia V, Khillan V, et al. Spontaneous cryptococcal peritonitis with fungemia in patients with decompensated cirrhosis: Report of two cases. Indian J Crit Care Med. 2014 Aug;18(8):536-9.სრული ტექსტი აბსტრაქტი
37. Alavi K, Atla PR, Haq T, et al. Coccidioidomycosis masquerading as eosinophilic ascites. Case Rep Gastrointest Med. 2015;2015:891910.სრული ტექსტი აბსტრაქტი
38. Hwang SY, Yu SJ, Lee JH, et al. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):259-64. აბსტრაქტი
39. Ferreira AO, Martins LN, Marinho RT, et al. Spontaneous bacterial peritonitis by Brucella in a cirrhotic patient. BMJ Case Rep. 2013;2013:bcr2013008629.სრული ტექსტი აბსტრაქტი
40. Sim JS, Kim HS, Oh KJ, et al. Spontaneous bacterial peritonitis with sepsis caused by Enterococcus hirae. J Korean Med Sci. 2012 Dec;27(12):1598-600.სრული ტექსტი აბსტრაქტი
41. Narciso-Schiavon JL, Borgonovo A, Marques PC, et al. Enterococcus casseliflavus and Enterococcus gallinarum as causative agents of spontaneous bacterial peritonitis. Ann Hepatol. 2015 Mar-Apr;14(2):270-2სრული ტექსტი აბსტრაქტი
42. Dlamini NR, Bhamjee A, Levick P, et al. Spontaneous bacterial peritonitis and pneumonia caused by Bordetella bronchiseptica. J Infect Dev Ctries. 2012 Jul 23;6(7):588-91.სრული ტექსტი აბსტრაქტი
43. Patel S, Gandhi D, Mehta V, et al. Plesiomonas shigelloides : an extremely rare cause of spontaneous bacterial peritonitis. Acta Gastroenterol Belg. 2016 Mar;79(1):52-3. აბსტრაქტი
44. Chinnock B, Fox C, Hendey GW. Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient. Ann Emerg Med. 2009 Jul;54(1):78-82. აბსტრაქტი
45. Bert F, Valla D, Moreau R, et al. Viridans group streptococci causing spontaneous bacterial peritonitis and bacteremia in patients with end-stage liver disease. Liver Transpl. 2008 May;14(5):710-1.სრული ტექსტი აბსტრაქტი
46. Ricart E, Soriano G, Novella MT, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol. 2000 Apr;32(4):596-602. აბსტრაქტი
47. Strauss E, Caly WR. Spontaneous bacterial peritonitis: a therapeutic update. Expert Rev Anti Infect Ther. 2006 Apr;4(2):249-60. აბსტრაქტი
48. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002 Jan;35(1):140-8. აბსტრაქტი
49. Navasa M, Rimola A, Rodés J. Bacterial infections in liver disease. Semin Liver Dis. 1997;17(4):323-33. აბსტრაქტი
50. Simberkoff MS, Moldover NH, Weiss G. Bactericidal and opsonic activity of cirrhotic ascites and nonascitic peritoneal fluid. J Lab Clin Med. 1978 May;91(5):831-9. აბსტრაქტი
51. Terg R, Fassio E, Guevara M, et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol. 2008 May;48(5):774-9. აბსტრაქტი
52. Bruns T, Lutz P, Stallmach A, et al. Low ascitic fluid protein does not indicate an increased risk for spontaneous bacterial peritonitis in current cohorts. J Hepatol. 2015 Aug;63(2):527-8.სრული ტექსტი აბსტრაქტი
53. Mo S, Bendtsen F, Wiese SS, et al. Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis. Scand J Gastroenterol. 2018 Feb;53(2):200-5.სრული ტექსტი აბსტრაქტი
54. Yildirim B, Sezgin N, Sari R, et al. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis. South Med J. 2002 Oct;95(10):1158-62. აბსტრაქტი
55. Saab S, Hernandez JC, Chi AC, et al. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol. 2009 Apr;104(4):993-1001. აბსტრაქტი
56. Loomba R, Wesley R, Bain A, et al. Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis. Clin Gastroenterol Hepatol. 2009 Apr;7(4):487-93. აბსტრაქტი
57. Cohen MJ, Sahar T, Benenson S, et al. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding. Cochrane Database Syst Rev. 2009;(2):CD004791.სრული ტექსტი აბსტრაქტი
58. Segarra-Newnham M, Henneman A. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding. Ann Pharmacother. 2010 Dec;44(12):1946-54. აბსტრაქტი
59. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Aug;74(2):1014-48.სრული ტექსტი აბსტრაქტი
60. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication].სრული ტექსტი
61. US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. March 2018 [internet publication].სრული ტექსტი
62. US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].სრული ტექსტი
63. Komolafe O, Roberts D, Freeman SC, et al. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2020 Jan 16;1:CD013125.სრული ტექსტი აბსტრაქტი
64. Goel A, Rahim U, Nguyen LH, et al. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis. Aliment Pharmacol Ther. 2017 Dec;46(11-12):1029-36.სრული ტექსტი აბსტრაქტი
65. Sidhu GS, Go A, Attar BM, et al. Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review. BMJ Open Gastroenterol. 2017;4(1):e000154.სრული ტექსტი აბსტრაქტი
66. Facciorusso A, Papagiouvanni I, Cela M, et al. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis. Liver Int. 2019 Aug;39(8):1448-58.სრული ტექსტი აბსტრაქტი
67. Wang W, Yang J, Liu C, et al. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis. Eur J Gastroenterol Hepatol. 2019 Aug;31(8):905-10.სრული ტექსტი აბსტრაქტი
68. Senzolo M, Cholongitas E, Burra P, et al. Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int. 2009 Sep;29(8):1189-93. აბსტრაქტი
69. Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019 Apr 20;393(10181):1597-608.სრული ტექსტი აბსტრაქტი
70. Mandorfer M, Bota S, Schwabl P, et al. Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014 Jun;146(7):1680-90.e1.სრული ტექსტი აბსტრაქტი
71. Trikudanathan G, Israel J, Cappa J, et al. Association between proton-pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis. Int J Clin Pract. 2011 Jun;65(6):674-8. აბსტრაქტი
72. Campbell MS, Obstein K, Reddy KR, et al. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci. 2008 Feb;53(2):394-8. აბსტრაქტი
73. Terg R, Casciato P, Garbe C, et al; Study Group of Cirrhosis Complications of the Argentine Association for the Study of Liver Disease. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015 May;62(5):1056-60. აბსტრაქტი
74. Makharia GK, Sharma BC, Bhasin DK, et al. Spontaneous bacterial peritonitis in a patient with gastric carcinoma. J Clin Gastroenterol. 1998 Oct;27(3):269-70. აბსტრაქტი
75. Chinnock B, Afarian H, Minnigan H, et al. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008 Sep;52(3):268-73. აბსტრაქტი
76. Chinnock B, Hendey GW, Minnigan H, et al. Clinical impression and ascites appearance do not rule out bacterial peritonitis. J Emerg Med. 2013 May;44(5):903-9. აბსტრაქტი
77. McGibbon A, Chen GI, Peltekian KM, et al. An evidence-based manual for abdominal paracentesis. Dig Dis Sci. 2007 Dec;52(12):3307-15. აბსტრაქტი
78. Nazeer SF, Dewbre H, Miller AH. Ultrasound-assisted paracentesis performed by emergency physicians versus the traditional technique: a prospective, randomized study. Am J Emerg Med. 2005 May;23(3):363-7. აბსტრაქტი
79. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-60.სრული ტექსტი აბსტრაქტი
80. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006 Oct;55 Suppl 6:vi1-12.სრული ტექსტი აბსტრაქტი
81. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.სრული ტექსტი აბსტრაქტი
82. Kuiper JJ, van Buuren HR, de Man RA. Ascites in cirrhosis: a review of management and complications. Neth J Med. 2007;65(8):283-8.სრული ტექსტი აბსტრაქტი
83. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142-53. აბსტრაქტი
84. Bernardi M, Carceni P, Navickis RJ, et al. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012 Apr;55(4):1172-81.სრული ტექსტი აბსტრაქტი
85. Rosenblatt R, Tafesh Z, Shen N, et al. Early Paracentesis in high-risk hospitalized patients: time for a new quality indicator. Am J Gastroenterol. 2019 Dec;114(12):1863-9.სრული ტექსტი აბსტრაქტი
86. Angeloni S, Nicolini G, Merli M, et al. Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. Am J Gastroenterol. 2003 Aug;98(8):1844-8. აბსტრაქტი
87. Riggio O, Angeloni S, Parente A, et al. Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis. World J Gastroenterol. 2008 Oct 7;14(37):5689-94.სრული ტექსტი აბსტრაქტი
88. Cereto F, Genesca J, Segura R. Validation of automated blood cell counters for the diagnosis of spontaneous bacterial peritonitis. Am J Gastroenterol. 2004 Jul;99(7):1400. აბსტრაქტი
89. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988 Nov;95(5):1351-5.სრული ტექსტი აბსტრაქტი
90. Chinnock B, Hendey GW. Can clear ascitic fluid appearance rule out spontaneous bacterial peritonitis? Am J Emerg Med. 2007 Oct;25(8):934-7. აბსტრაქტი
91. Wong CL, Holroyd-Leduc J, Thorpe KE, et al. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? 2008 Mar 12;299(10):1166-78. აბსტრაქტი
92. Thévenot T, Briot C, Macé V, et al; CFEHTP, ANGH and the PerDRISLA Study Group. The Periscreen strip is highly efficient for the exclusion of spontaneous bacterial peritonitis in cirrhotic outpatients. Am J Gastroenterol. 2016 Oct;111(10):1402-9. აბსტრაქტი
93. Chinnock B, Woolard RE, Hendey GW, et al. Sensitivity of a bedside reagent strip for the detection of spontaneous bacterial peritonitis in ED patients with ascites. Am J Emerg Med. 2019 Dec;37(12):2155-8.სრული ტექსტი აბსტრაქტი
94. Koulaouzidis A, Leontiadis GI, Abdullah M, et al. Leukocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1055-60. აბსტრაქტი
95. Parsi MA, Saadeh SN, Zein NN, et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology. 2008 Sep;135(3):803-7. აბსტრაქტი
96. Yellapu RK, Rajekar H, Martin JD, et al. Pneumatosis intestinalis and mesenteric venous gas - a manifestation of bacterascites in a patient with cirrhosis. J Postgrad Med. 2011 Jan-Mar:57(1);42-3.სრული ტექსტი აბსტრაქტი
97. Koulaouzidis A, Bhat S, Saeed AA. Spontaneous bacterial peritonitis. World J Gastroenterol. 2009 Mar 7;15(9):1042-9.სრული ტექსტი აბსტრაქტი
98. Lin CH, Shih FY, Ma MH, et al. Should bleeding tendency deter abdominal paracentesis? Dig Liver Dis. 2005 Dec;37(12):946-51. აბსტრაქტი
99. Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology. 1984 May-Jun;4(3):447-50. აბსტრაქტი
100. Zapater P, Frances R, Gonzalez-Navaja JM, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in non-infected patients with cirrhosis. Hepatology. 2008 Dec:48(6);1924-31.სრული ტექსტი აბსტრაქტი
101. Rogers GB, Russell LE, Preston PG, et al. Characterisation of bacteria in ascites -reporting the potential of culture-independent, molecular analysis. Eur J Clin Microbiol Infect Dis. 2010 May;29(5):533-41. აბსტრაქტი
102. Appenrodt B, Lehmann LE, Thyssen L, et al. Is detection of bacterial DNA in ascitic fluid of clinical relevance? Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1487-94. აბსტრაქტი
103. Yuan LY, Ke ZQ, Wang M, et al. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med. 2013 Nov;33(6):449-54.სრული ტექსტი აბსტრაქტი
104. Cekin Y, Cekin AH, Duman A, et al. The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci. 2013 Aug 20;10(10):1367-74.სრული ტექსტი აბსტრაქტი
105. Su DH, Zhuo C, Liao K, et al. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepatogastroenterology. 2013 Jun;60(124):641-6. აბსტრაქტი
106. Wu SS, Lin OS, Chin YY, et al. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol. 2001 Feb;34(2):215-21. აბსტრაქტი
107. Runyon BA, Hoefs JC. Spontaneous versus secondary bacterial peritonitis: differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy. Arch Intern Med. 1986 Aug;146(8):1563-5. აბსტრაქტი
108. Uygur-Bayramicli O, Dabak G, Dabak R. A clinical dilemma: abdominal tuberculosis. World J Gastroenterol. 2003 May;9(5):1098-101.სრული ტექსტი აბსტრაქტი
109. Riquelme A, Calvo M, Salech F, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculosis peritonitis: a meta-analysis. J Clin Gastroenterol. 2006 Sep;40(8):705-10. აბსტრაქტი
110. Runyon BA. Amylase levels in ascitic fluid. J Clin Gastroenterol. 1987 Apr;9(2):172-4. აბსტრაქტი
111. Bracher GA, Manocha AP, DeBanto JR, et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc. 1999 Jun;49(6):710-15. აბსტრაქტი
112. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247.სრული ტექსტი აბსტრაქტი
113. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985 May-Jun;5(3):457-62. აბსტრაქტი
114. Rimola A, Salmeron JM, Clemente G. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology. 1995 Mar;21(3):674-9. აბსტრაქტი
115. Gomez-Jimenez J, Ribera E, Gasser I, et al. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother. 1993;37:1587-92.სრული ტექსტი აბსტრაქტი
116. Figueiredo FAF, Coelho HSM, Alvariz RG, et al. Randomized trial comparing intravenous ceftriaxone with oral cefixime for treatment of spontaneous bacterial peritonitis (SBP) in cirrhotic patients: pilot study. Presented at: 5th United European Gastroenterology Week, Paris, 1996.
117. Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996 Oct;111(4):1011-7. აბსტრაქტი
118. Tuncer I, Topcu N, Durmus A, et al. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. Hepatogastroenterology. 2003;50:1426-30. აბსტრაქტი
119. Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial. Hepatology. 2016 Apr;63(4):1299-309. აბსტრაქტი
120. Jindal A, Kumar M, Bhadoria AS, et al. A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis. Liver Int. 2016 May;36(5):677-87. აბსტრაქტი
121. Sheikhbahaei S, Abdollahi A, Hafezi-Nejad N, et al. Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples. Int J Hepatol. 2014;2014:917856.სრული ტექსტი აბსტრაქტი
122. Ariza X, Castellote J, Lora-Tamayo J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 2012 Apr;56(4):825-32. აბსტრაქტი
123. Novovic S, Semb S, Olsen H, et al. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage. Scand J Gastroenterol. 2012 Feb;47(2):212-6. აბსტრაქტი
124. Reuken PA, Pletz MW, Baier M, et al. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther. 2012 May;35(10):1199-208. აბსტრაქტი
125. Angeloni S, Leboffe C, Parente A, et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008 May 7;14(17):2757-62.სრული ტექსტი აბსტრაქტი
126. Angeli P, Guarda S, Fasolato S, et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther. 2006 Jan 1;23(1):75-84.სრული ტექსტი აბსტრაქტი
127. Terg R, Cobas S, Fassio E, et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol. 2000;33:564-9. აბსტრაქტი
128. Iogna Prat L, Wilson P, Freeman SC, et al. Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2019 Sep 16;9:CD013120.სრული ტექსტი აბსტრაქტი
129. Chen TA, Lo GH, Lai KH, et al. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroenterol. 2005 Nov 21;11(43):6823-7.სრული ტექსტი აბსტრაქტი
130. Grange J. Randomized comparative study of moxifloxacin versus amoxicillin-clavulanate in the treatment of bacterial infection in cirrhotic patients. Hepatology. 2004;40(suppl 1):631.
131. Chavez-Tapia NC, Soares-Weiser K, Brezis M, et al. Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients. Cochrane Database Syst Rev. 2009;(1):CD002232.სრული ტექსტი აბსტრაქტი
132. Umgelter A, Reindl W, Miedaner M, et al. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009 Feb;37(1):2-8. აბსტრაქტი
133. Bhat G, Vandana KE, Bhatia S, et al. Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy. Indian J Gastroenterol. 2013 Sep;32(5):297-301. აბსტრაქტი
134. Badawy AA, Zaher TI, Sharaf SM, et al. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. World J Gastroenterol. 2013 Feb 28;19(8):1271-7.სრული ტექსტი აბსტრაქტი
135. Oliveira JC, Carrera E, Petry RC, et al. High prevalence of multidrug resistant bacteria in xirrhotic patients with spontaneous bacterial peritonitis: is it time to change the standard antimicrobial approach? Can J Gastroenterol Hepatol. 2019;2019:6963910.სრული ტექსტი აბსტრაქტი
136. Friedrich K, Nüssle S, Rehlen T, et al. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis. J Gastroenterol Hepatol. 2016 Jun;31(6):1191-5. აბსტრაქტი
137. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.სრული ტექსტი აბსტრაქტი
138. Choi CH, Han KH, Kim do Y, et al. Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized, prospective study [in Korean]. Taehan Kan Hakhoe Chi. 2002 Mar;8(1):52-60. აბსტრაქტი
139. Choi CH, Ahn SH, Kim DY, et al. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study. J Gastroenterol Hepatol. 2005 Aug;20(8):1215-22. აბსტრაქტი
140. Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol. 2005;42(suppl 1):S85-92. აბსტრაქტი
141. Tito L, Rimola A, Gines P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988 Jan-Feb;8(1):27-31. აბსტრაქტი
142. Runyon BA, McHutchinson JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 100 patients. Gastroenterology. 1991 Jun;100(6):1737-42. აბსტრაქტი
143. Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011 Mar;9(3):260-5. აბსტრაქტი
144. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994 Dec;20(6):1495-1501. აბსტრაქტი
145. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut. 2005 May;54(5):718-25.სრული ტექსტი აბსტრაქტი
146. Qureshi WA, Harshfield D, Shah H, et al. An unusual complication of paracentesis. Am J Gastroenterol. 1992 Sep;87(9):1209-11. აბსტრაქტი
147. Aagaard J, Jensen LI, Sorensen TI, et al. Recanalized umbilical vein in portal hypertension. AJR Am J Roentgenol. 1982 Dec;139(6):1107-10. აბსტრაქტი
148. Arnold C, Haag K, Blum HE, et al. Acute hemoperitoneum after large-volume paracentesis. Gastroenterology. 1997 Sep;113(3):978-82. აბსტრაქტი
149. Pache I, Bilodeau M. Severe hemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005;21:525-9.სრული ტექსტი აბსტრაქტი
150. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164-171. აბსტრაქტი
151. De Gottardi A, Thévenot T, Spahr, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009 Aug;7(8):906-9. აბსტრაქტი
152. Mallory A, Schaefer JW. Complications of diagnostic paracentesis in patients with liver disease. JAMA. 1978 Feb 13;239(7):628-30. აბსტრაქტი
153. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003 Jul;38(1):258-66. აბსტრაქტი
154. Hale BR Jr, Girzadas DV Jr. Application of 2-octyl-cyanoacrylate controls persistent ascites fluid leak. J Emerg Med. 2001 Jan;20(1):85-6. აბსტრაქტი
155. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;(9):CD002907.სრული ტექსტი აბსტრაქტი
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას